Rimonabant [rimonabant]
topical
9
- Terms
-
Acomplia
rimonabant hydrochlorid
Zimulti
-
Acomplia
N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride
Rimonabant Hydrochloride
SR 141716
SR 141716A
SR-141716A
SR141716
SR141716A
Zimulti
Persistent link
https://www.medvik.cz/link/D000077285
Definition
A pyrazole and piperidine derivative that acts as a selective cannabinoid type-1 receptor (CB1 RECEPTOR) antagonist. It inhibits the proliferation and maturation of ADIPOCYTES, improves lipid and glucose metabolism, and regulates food intake and energy balance. It is used in the management of OBESITY.
- DUI
- D000077285 MeSH Browser
- CUI
- M0235470
- CAS
- 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-
- History note
- 2019 (1994)
- Public note
- 2019; RIMONABANT was indexed under PYRAZOLES and PIPERIDINES 1994-2018
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.539.100
Betazole
D03.383.129.539.180
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
D03.383.129.539.200
Epirizole
D03.383.129.539.550
Muzolimine
D03.383.621.040
Alphaprodine
D03.383.621.320
Indoramin
D03.383.621.644
Perhexiline
D03.383.621.815
Piperoxan